These are new funds, and the plan for these funds is, as I mentioned before, to support the development of medical countermeasures. In my layperson's simple terms, that would be in support, for example, of large-scale vaccine clinical trials as well as manufacturing capability to produce a vaccine at scale for the Canadian population. Those are two really key examples of what that's for.
Those funds are available. They have not yet been deployed, but they're available to us now as we do the work to identify the most promising therapies that we can test here in Canada and then to have the manufacturing firepower to—for example, once a vaccine is discovered—be able to have a fill-and-finish capacity to make 40 million doses for the Canadian population. That capacity needs to be built, and we want to get a head start on that. That's what those funds are for.